Bionano Genomics Inc. (BNGO): Broker Consensus Forecast

Symbol and logo of brand Bionano Genomics, Inc. (BNGO)

Stable equipment supply chains and air freight for chips ensure uninterrupted laboratory supplies, as tracked via the market value visualization on GURU.Markets, where the indicator stands at 4.02. Bionano Genomics, Inc. (BNGO) management is focusing on engineering solutions for the Saphyr platform, reducing costs to combat liquidity shortages. Meanwhile, a sustainable approach to genomics minimizes energy consumption and reagent use, supporting the principles of sustainable development.

Bionano Genomics, Inc. (BNGO) Price Target Chart: for the period 07/04/2022 - 11/12/2026
Manufactured products of Bionano Genomics Inc.

To objectively assess the operational success of Bionano Genomics, Inc. (BNGO), investors must compare market value against the expectations of the professional community. The median price target aggregates investment bank forecasts, reflecting the balance between the uniqueness of Saphyr patents and capital shortage risks, which allows for the determination of the asset's fair valuation amid limited marketing and competition from sequencing leaders.

Competing companies

Price Target Chart TEM (tempus.com)|Price Target Chart Qiagen QGEN|IONS: Broker Consensus Forecast|Repligen Corp. - Analyst Consensus Forecast|Analyst Target Range Avidity Corp (RNA)|CRISPR Therapeutics AG (CRSP) - Price Target Chart|Average Forecast Price genedx.com (WGS)|RARE (Ultragenyx) - Analyst Consensus Forecast|Broker Consensus Forecast BEAM (Beam Therapeutics Inc)|Price Target Chart Sarepta Therapeutics Inc (SRPT)|Twist Bioscience Corp - Broker Consensus Forecast|Analyst Consensus Forecast TXG (10x Genomics, Inc.)|Analyst Consensus Forecast intelliatx.com NTLA|Stoke Therapeutics, Inc. - Analyst Consensus Forecast|BLFS: Price Target Chart|WVE: Analyst Consensus Forecast|MAZE - Analyst Median Target|Price Target Chart Sionna Therapeutics Inc|Average Forecast Price primemedicine.com PRME|Price Target Chart Taysha Gene Therapies, Inc. (TSHA)|uniQure NV - Broker Consensus Forecast|Analyst Consensus Forecast MGTX (MeiraGTx PLC)|Analyst Consensus Forecast REGENXBIO Corp RGNX|SLDB - Price Target Chart|OCGN (ocugen.com) - Broker Consensus Forecast|PacBio (PACB) - Price Target Chart|Average Forecast Price Benitec Biopharma Inc (BNTC)|Consensus Target DSGN|RCKT: Fair Value Consensus|Analyst Consensus Forecast FDMT|lexeotx.com (LXEO) - Analyst Target Range|Analyst Consensus Forecast KRRO (Korro Bio)|Editas Medicine Inc (EDIT) - Average Forecast Price|SLN - Price Target Chart|PRQR (ProQR Therapeutics N.V.) - Broker Consensus Forecast|codexis.com (CDXS) - Price Target Chart|Average Forecast Price sangamo.com (SGMO)|Price Target Chart Nautilus Biotechnology, Inc.|Consensus Target Metagenomi Inc. (MGX)|Analyst Consensus Forecast DTIL|Analyst Median Target generationbio.com|Analyst Consensus Forecast BOLD (Boundless Bio, Inc.)|XCUR - Consensus Target|IMNN - Price Target Chart|Analyst Median Target Phio Pharmaceuticals PHIO|MBIO (mustangbio.com) - Consensus Target|TransCode Therapeutics, Inc. - Fair Value Consensus|APDN (Applied DNA Sciences) - Analyst Consensus Forecast|bluebirdbio.com (BLUE) - Analyst Median Target|Price Target Chart ImmunoPrecise Antibodies (IPA)|Omega Therapeutics Inc - Broker Consensus Forecast|Analyst Consensus Forecast OMIC (Singular Genomics Systems Inc)|RGLS - Consensus Target|SYRS: Consensus Target|Analyst Median Target telesisbio.com TBIO|TCON: Analyst Consensus Forecast|UBX (Unity Biotechnology Inc.) - Price Target Chart